Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Maravai LifeSciences Holdings, Inc.
MRVI
FX & Other Adjustments
FX & Other Adjustments at other companies
Repligen
RGEN
$6.82M
+631%
Charles River Laboratories
CRL
-$18.55M
-160%
Revvity
RVTY
—
—
Bio-Rad Laboratories
BIO
—
—
Segments
By segment
See full
TriLink
$228K
—
Cygnus
$0
—
Other financials
Income statement
See full
Revenue
$65.8M
+40.5%
Gross profit
$33.7M
+336%
Operating income
-$2.2M
+95.6%
Net income
-$3.7M
+87.5%
EPS (diluted)
-$0.02
+90.5%
Balance sheet
See full
Cash & equivalents
$165.9M
-41.8%
Total debt
$270.9M
-17.1%
Total equity
$211.6M
-29.6%
Total assets
$713.2M
-25.7%
Cash flow
See full
Operating cash flow
$8.7M
+192%
CapEx
$4.4M
-1.4%
Free cash flow
$4.2M
+130%
Valuation
See full
Market cap
$902.74M
+204%
Enterprise value
$1.01B
+198%
P/S
4.4×
+3.2×
Profitability
See full
Gross margin
29.3%
-8.0pp
Operating margin
-82.2%
-16.6pp
Net margin
-51.1%
-9.9pp
FCF margin
-25.7%
—
Returns & leverage
See full
Return on equity
-40.8%
-4.0pp
Debt / equity
1.3×
+0.2×
Current ratio
5.9×
-0.1×
